
Sign up to save your podcasts
Or


Does the year 2025 mark a true, tangible shift toward biomarker-driven precision medicine for metastatic hormone-sensitive prostate cancer (mHSPC)?
Credit available for this activity expires: 11/18/26 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/latest-advances-mhspc-update-berlin-2025-2025a1000vlk?ecd=bdc_podcast_libsyn_mscpedu
By Medscape Podcasts4
77 ratings
Does the year 2025 mark a true, tangible shift toward biomarker-driven precision medicine for metastatic hormone-sensitive prostate cancer (mHSPC)?
Credit available for this activity expires: 11/18/26 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/latest-advances-mhspc-update-berlin-2025-2025a1000vlk?ecd=bdc_podcast_libsyn_mscpedu

138 Listeners

323 Listeners

551 Listeners

498 Listeners

1,308 Listeners

297 Listeners

258 Listeners

878 Listeners

14 Listeners

16 Listeners

294 Listeners

261 Listeners

3,361 Listeners

205 Listeners

95 Listeners

515 Listeners

61 Listeners

28 Listeners

247 Listeners